Srinivas Kantevari

600 citations

18 papers · 538 indexed · h-index 12

Co-authors: Dharmarajan Sriram Perumal Yogeeswari Balasubramanian Sridhar Shasi V. Kalivendi Nishant Jain Jonnalagadda Padma Sridevi Vagolu Siva Krishna Thirumal Yempala
Topics: Click Chemistry and Applications (13 papers)Synthesis and biological activity (9 papers)Synthesis and Biological Evaluation (9 papers)
Cited by: Organic Chemistry Infectious Diseases Toxicology
Journals: Journal of Medicinal Chemistry Tetrahedron Letters European Journal of Medicinal Chemistry
Partner nations: India Russia Poland

In The Last Decade

Srinivas Kantevari

17 papers receiving 529 citations

Peers

Countries citing papers authored by Srinivas Kantevari

Since Specialization

Citations

This map shows the geographic impact of Srinivas Kantevari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srinivas Kantevari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srinivas Kantevari more than expected).

Fields of papers citing papers by Srinivas Kantevari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srinivas Kantevari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srinivas Kantevari. The network helps show where Srinivas Kantevari may publish in the future.

Co-authorship network of co-authors of Srinivas Kantevari

This figure shows the co-authorship network connecting the top 25 collaborators of Srinivas Kantevari. A scholar is included among the top collaborators of Srinivas Kantevari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srinivas Kantevari. Srinivas Kantevari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Metal‐ and Solvent‐free, Methodical In situ Activation of Alkynes to Access Imidazo[1,2‐a]pyrazines from 2‐Cyanoimidazoles 2025 ·Asian Journal of Organic Chemistry ·(unknown),(unknown),(unknown),Balasubramanian Sridhar,Srinivas Kantevari	0
2	Imidazole-1,2,4-oxadiazole-piperazine hybrids as potent anticancer agents: Synthesis, biological evaluation and molecular docking 2025 ·Bioorganic Chemistry ·(unknown),(unknown),(unknown),(unknown),Balasubramanian Sridhar,Anjana Devi Tangutur,Srinivas Kantevari	2
3	5-Chloro-2-thiophenyl-1,2,3-triazolylmethyldihydroquinolines as dual inhibitors of Mycobacterium tuberculosis and influenza virus: Synthesis and evaluation 2019 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Vagolu Siva Krishna,(unknown),(unknown),(unknown),(unknown),Dmitri Tentler,Dharmarajan Sriram,Владимир В. Зарубаев,Srinivas Kantevari	11
4	Synthesis and evaluation of novel substituted 1,2,3-triazolyldihydroquinolines as promising antitubercular agents 2019 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Vagolu Siva Krishna,Dharmarajan Sriram,Srinivas Kantevari	25
5	Synthesis of novel morpholine, thiomorpholine and N-substituted piperazine coupled 2-(thiophen-2-yl)dihydroquinolines as potent inhibitors of Mycobacterium tuberculosis 2018 ·European Journal of Medicinal Chemistry ·(unknown),Vagolu Siva Krishna,Dharmarajan Sriram,Srinivas Kantevari	26
6	Synthesis of novel derivatives of 7,8‐dihydro‐6H‐imidazo[2,1‐b][1,3]benzothiazol‐5‐one and their virus‐inhibiting activity against influenza A virus 2018 ·Archiv der Pharmazie ·(unknown),(unknown),(unknown),Dmitri Tentler,(unknown),Alexander V. Slita,(unknown),Srinivas Kantevari	29
7	Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Jonnalagadda Padma Sridevi,Perumal Yogeeswari,Dharmarajan Sriram,Srinivas Kantevari	25
8	Click-based synthesis and antitubercular evaluation of dibenzofuran tethered thiazolyl-1,2,3-triazolyl acetamides 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Perumal Yogeeswari,Dharmarajan Sriram,Srinivas Kantevari	13
9	Click-based synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene-1,2,3-triazoles with piperidine, piperazine, morpholine and thiomorpholine appendages 2016 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Perumal Yogeeswari,Dharmarajan Sriram,Srinivas Kantevari	40
10	Synthesis and click reaction of tubulin polymerization inhibitor 9-azido-α-noscapine 2016 ·Research on Chemical Intermediates ·(unknown),(unknown),Balasubramanian Sridhar,Srinivas Kantevari	9
11	Development of Anionically Decorated Caged Neurotransmitters: In Vitro Comparison of 7‐Nitroindolinyl‐ and 2‐(p‐Phenyl‐o‐nitrophenyl)propyl‐Based Photochemical Probes 2016 ·ChemBioChem ·Srinivas Kantevari,Stefan Passlick,Hyung‐Bae Kwon,Matthew T. Richers,Bernardo L. Sabatini,Graham C. R. Ellis‐Davies	19
12	Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis 2014 ·Bioorganic & Medicinal Chemistry Letters ·Dinesh Addla,(unknown),(unknown),Perumal Yogeeswari,Dharmarajan Sriram,Srinivas Kantevari	26
13	Synthesis of novel l-rhamnose derived acyclic C-nucleosides with substituted 1,2,3-triazole core as potent sodium-glucose co-transporter (SGLT) inhibitors 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Abhinav Kanwal,S. Banerjee,Srinivas Kantevari	13
14	Synthesis of l-rhamnose derived chiral bicyclic triazoles as novel sodium-glucose transporter (SGLT) inhibitors 2014 ·Organic & Biomolecular Chemistry ·(unknown),Abhinav Kanwal,Balasubramanian Sridhar,S. Banerjee,Srinivas Kantevari	9
15	Rational design, synthesis and evaluation of novel-substituted 1,2,3-triazolylmethyl carbazoles as potent inhibitors of Mycobacterium tuberculosis 2014 ·Medicinal Chemistry Research ·(unknown),Perumal Yogeeswari,Dharmarajan Sriram,Srinivas Kantevari	31
16	Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis 2013 ·European Journal of Medicinal Chemistry ·Thirumal Yempala,Jonnalagadda Padma Sridevi,Perumal Yogeeswari,Dharmarajan Sriram,Srinivas Kantevari	47
17	Design, Synthesis, and Structure–Activity Correlations of Novel Dibenzo[b,d]furan, Dibenzo[b,d]thiophene, and N-Methylcarbazole Clubbed 1,2,3-Triazoles as Potent Inhibitors of Mycobacterium tuberculosis 2012 ·Journal of Medicinal Chemistry ·(unknown),(unknown),Perumal Yogeeswari,Dharmarajan Sriram,Nishant Jain,Balasubramanian Sridhar,(unknown),(unknown),Shasi V. Kalivendi,Srinivas Kantevari	202
18	3-O-Acyl triggered tandem Lewis acid catalyzed intramolecular cyclization of diacetone glucose derivatives to 5-O-acyl-3,6-anhydro-d-glucose 2011 ·Tetrahedron Letters ·Rajashaker Bantu,Hari Babu Mereyala,Lingaiah Nagarapu,Srinivas Kantevari	11

About Srinivas Kantevari

Srinivas Kantevari is a scholar working on Organic Chemistry, Infectious Diseases and Physiology, having authored 18 papers that have together received 538 indexed citations. Recurring topics across this work include Click Chemistry and Applications (13 papers), Synthesis and biological activity (9 papers) and Synthesis and Biological Evaluation (9 papers). The work is most often cited by research in Organic Chemistry (479 citations), Infectious Diseases (110 citations) and Toxicology (13 citations). Srinivas Kantevari has collaborated with scholars based in India, Russia and Poland. Frequent co-authors include Dharmarajan Sriram, Perumal Yogeeswari, Balasubramanian Sridhar, Shasi V. Kalivendi, Nishant Jain, Jonnalagadda Padma Sridevi, Vagolu Siva Krishna, Thirumal Yempala, S. Banerjee and Abhinav Kanwal. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact